Milrinone in congestive heart failure: Acute and chronic hemodynamic and clinical evaluation
- 1 August 1985
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 6 (2) , 453-459
- https://doi.org/10.1016/s0735-1097(85)80185-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failureAmerican Heart Journal, 1984
- Oral amrinone for the treatment of chronic congestive heart failure: Results of a multicenter randomized double-blind and placebo-controlled withdrawal studyJournal of the American College of Cardiology, 1984
- Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failureJournal of the American College of Cardiology, 1984
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying diseaseJournal of the American College of Cardiology, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.Circulation, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- Thermodilution cardiac output determination with a single flow-directed catheterAmerican Heart Journal, 1972